We are live on
!
Find out more
TG
TRV GP Portfolio holdings
AUM
$18.9M
1-Year Est. Return
541.67%
This Fund
S&P 500
This Quarter
Est. Return
+607.47%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$84.2M
(+132%)
Cap. Flow
-$38.5M
Cap. Flow
% of AUM
-25.99%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$38.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $143M | 96.6% |
3,034,083
| – | – |
|
|
CARM
2
DELISTED
Carisma Therapeutics
CARM
| $5.04M | 3.4% |
242,080
| – | – |
|
|
3
Rhythm Pharmaceuticals
RYTM
$7.28B
| – | – |
-1,781,437
| Closed | -$38.5M |
|
Similar funds
KA
FRGX
DHRFI
SA
YECIP
FFIM
ES
HCMT
TRV GP's Q4 2019 Portfolio in Review
As of Q4 2019, TRV GP held 3 positions worth $148M, up 132% from $63.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP withdrew a net $38.5M in Q4 2019, closing 1 position. Its most notable exit was Rhythm Pharmaceuticals, an estimated $38.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP fully exited Rhythm Pharmaceuticals in Q4 2019, selling an estimated $38.5M.
- TRV GP's ten largest holdings make up 100% of its $148M portfolio in Q4 2019.
- TRV GP opened 0 new positions and closed 1 in Q4 2019.
- TRV GP's portfolio value rose 132% quarter-over-quarter to $148M.
Based on TRV GP's 13F filing for Q4 2019, filed 5 Feb 2020.